Cargando…

Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is one of the most common malignancies. Early diagnosis is critical for guiding the therapeutic management of ESCC. It is imperative to find more effective biomarkers of ESCC. METHODS: To identify novel biomarkers for esophageal squamous cell car...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Xi, Ding, Ming, Yu, Mei-Lan, Feng, Ming-Xiang, Tan, Li-Jie, Zhao, Fu-Kun
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087317/ https://www.ncbi.nlm.nih.gov/pubmed/20546628 http://dx.doi.org/10.1186/1471-2407-10-290

Ejemplares similares

Proteomic Identification of the Galectin-1-Involved Molecular Pathways in Urinary Bladder Urothelial Carcinoma
por: Li, Chien-Feng, et al.
Publicado: (2018)

Clinical significance of galectin-7 in vulvar squamous cell carcinoma
por: JIANG, YING, et al.
Publicado: (2015)

Galectin-1 Expression Is Associated with the Response and Survival Following Preoperative Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma
por: Li, Shau-Hsuan, et al.
Publicado: (2021)

ESCCAL-1 promotes cell-cycle progression by interacting with and stabilizing galectin-1 in esophageal squamous cell carcinoma
por: Cui, Yuanbo, et al.
Publicado: (2022)

Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma
por: Yu, Jun, et al.
Publicado: (2019)

Identification of KIF4A as a prognostic biomarker for esophageal squamous cell carcinoma
por: Wang, Lingwei, et al.
Publicado: (2021)

Tissue‐based quantitative proteomics to screen and identify the potential biomarkers for early recurrence/metastasis of esophageal squamous cell carcinoma
por: Cai, Xu‐Wei, et al.
Publicado: (2018)

Identification of Biomarkers for Esophageal Squamous Cell Carcinoma Using Feature Selection and Decision Tree Methods
por: Tung, Chun-Wei, et al.
Publicado: (2013)

RBBP7 is a prognostic biomarker in patients with esophageal squamous cell carcinoma
por: Yu, Ning, et al.
Publicado: (2018)

Identification of Galectin-3 as Potential Biomarkers for Renal Fibrosis by RNA-Sequencing and Clinicopathologic Findings of Kidney Biopsy
por: Ou, Shuo-Ming, et al.
Publicado: (2021)

Proteomic analysis indicates the importance of TPM3 in esophageal squamous cell carcinoma invasion and metastasis
por: Yu, Shao-Bin, et al.
Publicado: (2017)

RNA-Binding Proteins CLK1 and POP7 as Biomarkers for Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma
por: Yang, Xiuping, et al.
Publicado: (2021)

Proteomic identification of galectin-11 and 14 ligands from Haemonchus contortus
por: Sakthivel, Dhanasekaran, et al.
Publicado: (2018)

Galectin-7 in Epithelial Homeostasis and Carcinomas
por: Advedissian, Tamara, et al.
Publicado: (2017)

Identification of combinatorial miRNA panels derived from extracellular vesicles as biomarkers for esophageal squamous cell carcinoma
por: Wang, Yaojie, et al.
Publicado: (2023)

Serum proteomics unveil characteristic protein diagnostic biomarkers and signaling pathways in patients with esophageal squamous cell carcinoma
por: Liu, Wenhu, et al.
Publicado: (2022)

Identification of Serum MicroRNAs as Novel Biomarkers in Esophageal Squamous Cell Carcinoma Using Feature Selection Algorithms
por: Zheng, Deqiang, et al.
Publicado: (2019)

Targeting CDC7 improves sensitivity to chemotherapy of esophageal squamous cell carcinoma
por: Cao, Ji-Xiang, et al.
Publicado: (2018)

Galectin-8 Expression in Laryngeal Squamous Cell Carcinoma
por: Dong, Geun Woo, et al.
Publicado: (2009)

Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB)
por: Zhu, Yanping, et al.
Publicado: (2019)

Galectins as Cancer Biomarkers
por: Balan, Vitaly, et al.
Publicado: (2010)

Biomarkers of apoptosis and survival in esophageal squamous cell carcinoma
por: Takikita, Mikiko, et al.
Publicado: (2009)

Early identification of esophageal squamous neoplasm by hyperspectral endoscopic imaging
por: Wu, I-Chen, et al.
Publicado: (2018)

Molecular Characterization of Esophageal Squamous Cell Carcinoma Using Quantitative Proteomics
por: Mangalaparthi, Kiran K., et al.
Publicado: (2023)

Mining novel biomarkers for prognosis of gastric cancer with serum proteomics
por: Qiu, Fu-Ming, et al.
Publicado: (2009)

Identification of Biomarker for Cutaneous Squamous Cell Carcinoma Using Microarray Data Analysis
por: Wei, Wei, et al.
Publicado: (2018)

Extracellular distribution of galectin-10 in the esophageal mucosa of patients with eosinophilic esophagitis
por: Albinsson, Sofie, et al.
Publicado: (2023)

Identification of galectin-1 as a novel mediator for chemoresistance in chronic myeloid leukemia cells
por: Luo, Wu, et al.
Publicado: (2016)

Elevated serum eotaxin and IP‐10 levels as potential biomarkers for the detection of esophageal squamous cell carcinoma
por: Chang, Chen, et al.
Publicado: (2021)

Identification of VPS13C as a Galectin-12-Binding Protein That Regulates Galectin-12 Protein Stability and Adipogenesis
por: Yang, Ri-Yao, et al.
Publicado: (2016)

Obesity Potentiates Esophageal Squamous Cell Carcinoma Growth and Invasion by AMPK-YAP Pathway
por: Liu, Jia-Huang, et al.
Publicado: (2020)

Galectin 3 expression in primary oral squamous cell carcinomas
por: Weber, Manuel, et al.
Publicado: (2017)

Deep proteome profiling promotes whole proteome characterization and drug discovery for esophageal squamous cell carcinoma
por: Liu, Wei, et al.
Publicado: (2022)

Identification of Immune-Cell-Related Prognostic Biomarkers of Esophageal Squamous Cell Carcinoma Based on Tumor Microenvironment
por: Cui, Yiyao, et al.
Publicado: (2021)

Galectin-7 as a potential predictive marker of chemo-and/or radio-therapy resistance in oral squamous cell carcinoma
por: Matsukawa, Sho, et al.
Publicado: (2014)

Proteomics Reveal the Inhibitory Mechanism of Levodopa Against Esophageal Squamous Cell Carcinoma
por: Li, Zhenzhen, et al.
Publicado: (2020)

Metabolomics of Esophageal Squamous Cell Carcinoma Tissues: Potential Biomarkers for Diagnosis and Promising Targets for Therapy
por: Xu, Jia, et al.
Publicado: (2022)

The efficacy and safety of sintilimab combined with chemotherapy as the first-line treatment for metastatic esophageal squamous cell carcinoma
por: Zhao, Zheng, et al.
Publicado: (2023)

The Role of DBR1 as a Candidate Prognosis Biomarker in Esophageal Squamous Cell Carcinoma
por: Xu, Xiaoqin, et al.
Publicado: (2022)

T-cell immunoglobulin and mucin domain-containing protein-3 and galectin-9 protein expression: Potential prognostic significance in esophageal squamous cell carcinoma for Chinese patients
por: Hou, Nan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_afe29tu169gm12l0o60cb3gc10